GlassScriptPhysician profile
Thomas H Myers
NPI 1255375820
$71,948.48
in general payments reported to CMS, 2019-2025
30 companies · $7,432 in 2025
The $7,432 reported for 2025 was more than what 85% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $14K · 2021: $10K · 2022: $8,692 · 2023: $8,450 · 2024: $6,032 · 2025: $7,432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $19K · Consulting Fee: $1,250 · Food and Beverage: $1,191 · Travel and Lodging: $928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $18,544.28 |
| Consulting Fee | $1,250.00 |
| Food and Beverage | $1,190.88 |
| Travel and Lodging | $928.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $62,841.95 | 2019-2025 | Donjoy, Procare |
| International Life Sciences | $3,000.00 | 2020 | |
| Moximed, INC | $1,391.01 | 2025 | Misha Knee System, Small, Left |
| Stryker Corporation | $836.84 | 2019 | |
| Encore Medical, LP | $751.95 | 2019 | |
| Arthrex, INC. | $642.16 | 2023 | |
| Medacta USA, INC. | $589.83 | 2019 | |
| Miach Orthopaedics, INC. | $521.73 | 2024-2025 | |
| United Orthopedics LLC | $488.20 | 2023 | |
| Smith+Nephew, INC. | $329.09 | 2022-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System |
| Medical Device Business Services, INC. | $87.25 | 2019 | |
| Galt Pharmaceuticals, LLC | $64.19 | 2023 | Orphengesic Forte |
| Tenex Health INC. | $58.15 | 2019 | |
| Depuy Synthes Sales INC. | $52.35 | 2019-2020 | |
| Molnlycke Health Care US, LLC | $33.48 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $32.48 | 2022-2023 | Seglentis |
| Zyla Life Sciences, INC. | $32.23 | 2019 | |
| Heraeus Medical, LLC. | $26.06 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $24.33 | 2024 | Zilretta, Iovera, Exparel |
| Davol INC. | $18.47 | 2021 | |
| Pacira Therapeutics, INC. | $17.17 | 2021 | |
| Next Science LLC | $16.30 | 2022 | |
| Medtronic Vascular, INC. | $16.24 | 2019 | |
| Horizon Therapeutics Plc | $13.31 | 2022 | |
| Anika Therapeutics, INC. | $12.72 | 2023 | Twist |
| Fidia Pharma USA INC. | $12.41 | 2019 | |
| Bioventus LLC | $11.87 | 2019 | |
| Think Surgical, INC. | $10.89 | 2023 | |
| Orthofix Medical, INC. | $9.61 | 2021 | |
| Ermi LLC | $6.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Myers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.